Pricing Log in Create free account

Alnylam Pharmaceuticals, Inc. (ALNY) vs BeOne Medicines Ltd. - Sponsored ADR (ONC)

Alnylam Pharmaceuticals, Inc. and BeOne Medicines Ltd. - Sponsored ADR are both Biotechnology companies. BeOne Medicines Ltd. - Sponsored ADR is the larger, with a market value of $39.0B against $31.3B — 1.2× the size. Alnylam Pharmaceuticals, Inc. trades at the lower P/E: 39.5× against 62.6×. Alnylam Pharmaceuticals, Inc. grew revenue faster over the last twelve months: 95.1% against 34.4%. Alnylam Pharmaceuticals, Inc. has the higher net margin (16.1% vs 10.7%) and the lower return on invested capital (0.00% vs 60.2%). Across the 21 metrics below, Alnylam Pharmaceuticals, Inc. leads on 11 and BeOne Medicines Ltd. - Sponsored ADR on 10.

Valuation

Metric ALNY ONC Biotechnology median
P/E 39.50 62.55 8.50
P/S 6.45 6.72 9.71
P/B 22.87 7.96 2.13
Price to free cash flow 37.78 31.43 20.82
EV/EBITDA 27.19 34.59 0.64
EV/Sales 5.97 6.08 9.21
Earnings yield 2.53% 1.60% (33.15%)
Free cash flow yield 2.65% 3.18% (25.50%)

Profitability

Metric ALNY ONC Biotechnology median
Gross margin 79.65% 88.89% 65.16%
Operating margin 20.81% 15.06% 0.00%
Net margin 16.13% 10.70% 0.00%
Free cash flow margin 17.07% 21.70% 0.00%
Return on equity 96.55% 14.66% (56.36%)
Return on assets 15.30% 8.47% (48.04%)
Return on invested capital 0.00% 60.22% 0.00%

Growth

Metric ALNY ONC Biotechnology median
Revenue growth (TTM) 95.14% 34.35% 6.02%
EPS growth (last fiscal year) 206.88% 141.34% 30.26%
Revenue growth, 5-year CAGR 49.77% 76.85% 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ALNY ONC Biotechnology median
Debt to equity 0.75 0.17 0.00
Current ratio 3.05 3.41 4.72
Net debt to EBITDA (3.41) (6.09) 0.96

Dividend

Metric ALNY ONC Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric ALNY ONC Biotechnology median
Market cap 31.32b 39.01b 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack